Home›Search›Molecular Therapy: Oncolytics

Molecular Therapy: Oncolytics

Elsevier · United Kingdom

eISSN2372-7705

✓ DOAJ✓ Open Access

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ PubMed/MEDLINE56

✓ Corroboration (2 more)+12

Total68

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

Aims & Scope✦ Inferred from recent articles

Molecular Therapy: Oncolytics publishes research on engineered biologics for cancer treatment, including oncolytic viruses, engineered T cells, and antibody-drug conjugates. The journal focuses on therapies that modulate the tumor microenvironment, enhance anti-tumor immunity, and target specific cancer antigens. Studies investigate mechanisms of action, therapeutic efficacy in preclinical models, and potential clinical applications.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published—

StatusActive

Total Publications—

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

APC Cost$3,900Above median

Peer ReviewAnonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Elsevier

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2372-7705

✅

Indexed in a trusted database?

DOAJ, PubMed

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

$3,900

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Research Topics (OpenAlex)

Virus-based gene therapy researchCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer-related molecular mechanisms researchMicroRNA in disease regulationViral Infectious Diseases and Gene Expression in InsectsCancer Research and TreatmentsRNA modifications and cancerRNA Interference and Gene DeliveryCircular RNAs in diseases

Frequently asked questions about Molecular Therapy: Oncolytics

Is Molecular Therapy: Oncolytics a predatory journal?

PubScope has no integrity flags on record for Molecular Therapy: Oncolytics: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 68/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Molecular Therapy: Oncolytics?

Molecular Therapy: Oncolytics is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.

Is Molecular Therapy: Oncolytics indexed in Scopus and Web of Science?

Molecular Therapy: Oncolytics is indexed in DOAJ.

How much does it cost to publish in Molecular Therapy: Oncolytics?

Molecular Therapy: Oncolytics charges an article processing charge (APC) of about $3,900 for open-access publication.